General Electric announced today it would shell out $587 million for Clarient, a maker of cancer diagnostic solutions. Clarient shares have soared 33% on the news.
Continue reading GE Strikes a Healthy Deal for Cancer Diagnostics Company Clarient
GE Strikes a Healthy Deal for Cancer Diagnostics Company Clarient originally appeared on DailyFinance on Fri, 22 Oct 2010 12:40:00.
Filed Under: General Electric